India bans exports of alleged coronavirus drug

It will be limited to fulfilling existing contracts and humanitarian grounds.

India has banned the exports of a malaria drug backed by US President Donald Trump amidst a run on supplies globally, even as preliminary findings emerge that the medication isn’t better than regular care in the treatment of the coronavirus.

Exports of hydroxychloroquine will be limited to fulfilling existing contracts, whilst certain shipments on humanitarian grounds may also be allowed on a case-by-case basis, according to a statement issued 25 March by the Directorate General of Foreign Trade.

India has some of the world’s largest manufacturers of the finished drug as well as its component ingredients, and the move is likely to crimp global supply at a time when the medication is receiving unprecedented global attention.

Hospitals and consumers in the US are stockpiling the drug after Trump called it a “game changer” in the treatment of the coronavirus and vowed to make it widely available. However, there is no conclusive scientific evidence that hydroxychloroquine can treat the infection from the novel pathogen.

Also Read

Dental radiology equipment market to grow by $2.45b by 2028

What to expect with Australia’s $739m Frankston Hospital Redevelopment?

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit